Learnings from cross-border biosimilar pricing policies in Europe

Expert Rev Pharmacoecon Outcomes Res. 2024 Mar 26:1-4. doi: 10.1080/14737167.2024.2334343. Online ahead of print.NO ABSTRACTPMID:38530083 | DOI:10.1080/14737167.2024.2334343

Source: Expert Review of Pharmacoeconomics and Outcomes Research - March 26, 2024 Category: Health Management Authors: Steven Simoens Teresa Barcina Lacosta Andr ás Inotai Source Type: research